Michael Charlton to Cardiovascular Diseases
This is a "connection" page, showing publications Michael Charlton has written about Cardiovascular Diseases.
Connection Strength
1.700
-
Predictors of Cardiovascular Events After Liver Transplantation. Clin Liver Dis. 2017 05; 21(2):367-379.
Score: 0.353
-
Nonalcoholic Fatty Liver Disease and Liver Transplantation. Clin Liver Dis. 2016 May; 20(2):403-17.
Score: 0.334
-
Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events. Liver Transpl. 2014 Jul; 20(7):791-7.
Score: 0.292
-
Posttransplant metabolic syndrome: new evidence of an epidemic and recommendations for management. Liver Transpl. 2011 Jan; 17(1):1-6.
Score: 0.231
-
Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels. Liver Transpl. 2011 Jan; 17(1):23-31.
Score: 0.231
-
Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study. Transplantation. 2017 12; 101(12):2873-2882.
Score: 0.093
-
Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation. Liver Transpl. 2010 Aug; 16(8):990-8.
Score: 0.056
-
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010 Jun; 10(6):1420-7.
Score: 0.055
-
Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol. 2010 Jul; 53(1):199-206.
Score: 0.055